Tumour cell–derived extracellular vesicles interact with mesenchymal stem cells to modulate the microenvironment and enhance cholangiocarcinoma growth

References

• Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999; 284: 143–7.
   PubMed Web of Science ®Google Scholar
• Liechty KW, MacKenzie TC, Shaaban AF, Radu A, Moseley AM, Deans R et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med. 2000; 6: 1282–6.
   PubMed Web of Science ®Google Scholar
• De Bruyn C, Najar M, Raicevic G, Meuleman N, Pieters K, Stamatopoulos B et al. A rapid, simple, and reproducible method for the isolation of mesenchymal stromal cells from Wharton's jelly without enzymatic treatment. Stem Cells Dev. 2011; 20: 547–57.
   PubMed Web of Science ®Google Scholar
• Spaeth EL, Dembinski JL, Sasser AK, Watson K, Klopp A, Hall B et al. Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS One. 2009; 4: e4992.
   PubMed Web of Science ®Google Scholar
• Quante M, Tu SP, Tomita H, Gonda T, Wang SS, Takashi S et al. Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth. Cancer Cell. 2011; 19: 257–72.
   PubMed Web of Science ®Google Scholar
• Ogawa M, LaRue AC, Drake CJ. Hematopoietic origin of fibroblasts/myofibroblasts: its pathophysiologic implications. Blood. 2006; 108: 2893–6.
   PubMed Web of Science ®Google Scholar
• Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature. 2007; 449: 557–63.
   PubMed Web of Science ®Google Scholar
• Lu YR, Yuan Y, Wang XJ, Wei LL, Chen YN, Cong C et al. The growth inhibitory effect of mesenchymal stem cells on tumor cells in vitro and in vivo. Cancer Biol Ther. 2008; 7: 245–51.
   PubMed Web of Science ®Google Scholar
• Hamada H, Kobune M, Nakamura K, Kawano Y, Kato K, Honmou O et al. Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy. Cancer Sci. 2005; 96: 149–56.
   PubMed Web of Science ®Google Scholar
• Ohno S, Tachibana M, Fujii T, Ueda S, Kubota H, Nagasue N. Role of stromal collagen in immunomodulation and prognosis of advanced gastric carcinoma. Int J Cancer. 2002; 97: 770–4.
   PubMed Web of Science ®Google Scholar
• Keleg S, Buchler P, Ludwig R, Buchler MW, Friess H. Invasion and metastasis in pancreatic cancer. Mol Cancer. 2003; 2: 14.
   PubMedGoogle Scholar
• Qiao L, Xu Z, Zhao T, Zhao Z, Shi M, Zhao RC et al. Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model. Cell Res. 2008; 18: 500–7.
   PubMed Web of Science ®Google Scholar
• Li L, Tian H, Chen Z, Yue W, Li S, Li W. Inhibition of lung cancer cell proliferation mediated by human mesenchymal stem cells. Acta Biochim Biophys Sin (Shanghai). 2011; 43: 143–8.
   Web of Science ®Google Scholar
• Khakoo AY, Pati S, Anderson SA, Reid W, Elshal MF, Rovira II et al. Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. J Exp Med. 2006; 203: 1235–47.
   PubMed Web of Science ®Google Scholar
• Cho JA, Park H, Kim HK, Lim EH, Seo SW, Choi JS et al. Hyperthermia-treated mesenchymal stem cells exert antitumor effects on human carcinoma cell line. Cancer. 2009; 115: 311–23.
   PubMed Web of Science ®Google Scholar
• Patel T. Cholangiocarcinoma – controversies and challenges. Nat Rev Gastroenterol Hepatol. 2011; 8: 189–200.
   PubMed Web of Science ®Google Scholar
• Sirica AE, Dumur CI, Campbell DJ, Almenara JA, Ogunwobi OO, Dewitt JL. Intrahepatic cholangiocarcinoma progression: prognostic factors and basic mechanisms. Clin Gastroenterol Hepatol. 2009; 7: S68–78.
   Web of Science ®Google Scholar
• Sirica AE. The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma. Nat Rev Gastroenterol Hepatol. 2012; 9: 44–54.
   Web of Science ®Google Scholar
• Kajiyama K, Maeda T, Takenaka K, Sugimachi K, Tsuneyoshi M. The significance of stromal desmoplasia in intrahepatic cholangiocarcinoma: a special reference of ‘scirrhous-type’ and ‘nonscirrhous-type’ growth. Am J Surg Pathol. 1999; 23: 892–902.
   PubMed Web of Science ®Google Scholar
• Sirica AE, Campbell DJ, Dumur CI. Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma. Curr Opin Gastroenterol. 2011; 27: 276–84.
   PubMed Web of Science ®Google Scholar
• Egeblad M, Nakasone ES, Werb Z. Tumors as organs: complex tissues that interface with the entire organism. Dev Cell. 2010; 18: 884–901.
   PubMed Web of Science ®Google Scholar
• Thery C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol. 2009; 9: 581–93.
   PubMed Web of Science ®Google Scholar
• Skog J, Wurdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008; 10: 1470–6.
   PubMed Web of Science ®Google Scholar
• Saunderson SC, Schuberth PC, Dunn AC, Miller L, Hock BD, MacKay PA et al. Induction of exosome release in primary B cells stimulated via CD40 and the IL-4 receptor. J Immunol. 2008; 180: 8146–52.
   PubMed Web of Science ®Google Scholar
• Kogure T, Lin WL, Yan IK, Braconi C, Patel T. Intercellular nanovesicle-mediated microRNA transfer: a mechanism of environmental modulation of hepatocellular cancer cell growth. Hepatology. 2011; 54: 1237–48.
   PubMed Web of Science ®Google Scholar
• Gutwein P, Stoeck A, Riedle S, Gast D, Runz S, Condon TP et al. Cleavage of L1 in exosomes and apoptotic membrane vesicles released from ovarian carcinoma cells. Clin Cancer Res. 2005; 11: 2492–501.
   PubMed Web of Science ®Google Scholar
• Kogure T, Yan I, Lin W, Patel T. Extracellular vesicle–mediated transfer of a novel long noncoding RNA TUC339: a mechanism of intercellular signaling in human hepatocellular cancer. Genes Cancer. 2013; 4: 261–72.
   PubMedGoogle Scholar
• Marienfeld C, Tadlock L, Yamagiwa Y, Patel T. Inhibition of cholangiocarcinoma growth by tannic acid. Hepatology. 2003; 37: 1097–104.
   PubMed Web of Science ®Google Scholar
• Nakahara H, Dennis JE, Bruder SP, Haynesworth SE, Lennon DP, Caplan AI. In vitro differentiation of bone and hypertrophic cartilage from periosteal-derived cells. Exp Cell Res. 1991; 195: 492–503.
   PubMed Web of Science ®Google Scholar
• Lazarus HM, Koc ON, Devine SM, Curtin P, Maziarz RT, Holland HK et al. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant. 2005; 11: 389–98.
   PubMed Web of Science ®Google Scholar
• Kogure T, Patel T. Isolation of extracellular nanovesicle microRNA from liver cancer cells in culture. Methods Mol Biol. 2013; 1024: 11–18.
   PubMedGoogle Scholar
• Yamagiwa Y, Marienfeld C, Tadlock L, Patel T. Translational regulation by p38 mitogen-activated protein kinase signaling during human cholangiocarcinoma growth. Hepatology. 2003; 38: 158–66.
   Web of Science ®Google Scholar
• Wehbe H, Henson R, Meng F, Mize-Berge J, Patel T. Interleukin-6 contributes to growth in cholangiocarcinoma cells by aberrant promoter methylation and gene expression. Cancer Res. 2006; 66: 10517–24.
   PubMed Web of Science ®Google Scholar
• Park J, Tadlock L, Gores GJ, Patel T. Inhibition of interleukin 6-mediated mitogen-activated protein kinase activation attenuates growth of a cholangiocarcinoma cell line. Hepatology. 1999; 30: 1128–33.
   PubMed Web of Science ®Google Scholar
• Braconi C, Patel T. Cholangiocarcinoma: new insights into disease pathogenesis and biology. Infect Dis Clin North Am. 2010; 24: 871–84, vii.
   PubMed Web of Science ®Google Scholar
• Prockop DJ, Oh JY. Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation. Mol Ther. 2012; 20: 14–20.
   PubMed Web of Science ®Google Scholar
• Zischek C, Niess H, Ischenko I, Conrad C, Huss R, Jauch KW et al. Targeting tumor stroma using engineered mesenchymal stem cells reduces the growth of pancreatic carcinoma. Ann Surg. 2009; 250: 747–53.
   PubMed Web of Science ®Google Scholar
• Hannafon BN, Ding WQ. Intercellular communication by exosome-derived microRNAs in cancer. Int J Mol Sci. 2013; 14: 14240–69.
   PubMed Web of Science ®Google Scholar
• Gu J, Qian H, Shen L, Zhang X, Zhu W, Huang L et al. Gastric cancer exosomes trigger differentiation of umbilical cord derived mesenchymal stem cells to carcinoma-associated fibroblasts through TGF-beta/Smad pathway. PLoS One. 2012; 7: e52465.
   PubMed Web of Science ®Google Scholar
• Cho JA, Park H, Lim EH, Lee KW. Exosomes from breast cancer cells can convert adipose tissue-derived mesenchymal stem cells into myofibroblast-like cells. Int J Oncol. 2012; 40: 130–8.
   PubMed Web of Science ®Google Scholar
• Cho JA, Park H, Lim EH, Kim KH, Choi JS, Lee JH et al. Exosomes from ovarian cancer cells induce adipose tissue-derived mesenchymal stem cells to acquire the physical and functional characteristics of tumor-supporting myofibroblasts. Gynecol Oncol. 2011; 123: 379–86.
   PubMed Web of Science ®Google Scholar
• Tsai KS, Yang SH, Lei YP, Tsai CC, Chen HW, Hsu CY et al. Mesenchymal stem cells promote formation of colorectal tumors in mice. Gastroenterology. 2011; 141: 1046–56.
   PubMed Web of Science ®Google Scholar
• Shinagawa K, Kitadai Y, Tanaka M, Sumida T, Kodama M, Higashi Y et al. Mesenchymal stem cells enhance growth and metastasis of colon cancer. Int J Cancer. 2010; 127: 2323–33.
   PubMed Web of Science ®Google Scholar
• De Boeck A, Pauwels P, Hensen K, Rummens JL, Westbroek W, Hendrix A et al. Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression through paracrine neuregulin 1/HER3 signalling. Gut. 2013; 62: 550–60.
   PubMed Web of Science ®Google Scholar
• De Boeck A, Narine K, De Neve W, Mareel M, Bracke M, De Wever O. Resident and bone marrow-derived mesenchymal stem cells in head and neck squamous cell carcinoma. Oral Oncol. 2010; 46: 336–42.
   PubMed Web of Science ®Google Scholar
• Liu J, Han G, Liu H, Qin C. Suppression of cholangiocarcinoma cell growth by human umbilical cord mesenchymal stem cells: a possible role of Wnt and Akt signaling. PLoS One. 2013; 8: e62844.
   Web of Science ®Google Scholar
• Klopp AH, Gupta A, Spaeth E, Andreeff M, Marini F. Concise review: dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth?. Stem Cells. 2011; 29: 11–19.
   PubMed Web of Science ®Google Scholar
• Tadlock L, Patel T. Involvement of p38 mitogen-activated protein kinase signaling in transformed growth of a cholangiocarcinoma cell line. Hepatology. 2001; 33: 43–51.
   PubMed Web of Science ®Google Scholar
• Braconi C, Swenson E, Kogure T, Huang N, Patel T. Targeting the IL-6 dependent phenotype can identify novel therapies for cholangiocarcinoma. PLoS One. 2010; 5: e15195.
   PubMed Web of Science ®Google Scholar
• Tu B, Du L, Fan QM, Tang Z, Tang TT. STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma. Cancer Lett. 2012; 325: 80–8.
   PubMed Web of Science ®Google Scholar
• Huang WH, Chang MC, Tsai KS, Hung MC, Chen HL, Hung SC. Mesenchymal stem cells promote growth and angiogenesis of tumors in mice. Oncogene. 2013; 32: 4343–54.
   PubMed Web of Science ®Google Scholar
• Owen JD, Strieter R, Burdick M, Haghnegahdar H, Nanney L, Shattuck-Brandt R et al. Enhanced tumor-forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/growth-regulated cytokine beta and gamma proteins. Int J Cancer. 1997; 73: 94–103.
   PubMed Web of Science ®Google Scholar
• Haghnegahdar H, Du JG, Wang DZ, Strieter RM, Burdick MD, Nanney LB et al. The tumorigenic and angiogenic effects of MGSA/GRO proteins in melanoma. J Leukocyte Biol. 2000; 67: 53–62.
   PubMed Web of Science ®Google Scholar